201 related articles for article (PubMed ID: 16234970)
1. Novel assessment of bone using time-resolved transcutaneous Raman spectroscopy.
Draper ER; Morris MD; Camacho NP; Matousek P; Towrie M; Parker AW; Goodship AE
J Bone Miner Res; 2005 Nov; 20(11):1968-72. PubMed ID: 16234970
[TBL] [Abstract][Full Text] [Related]
2. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent?
Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL
Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941
[TBL] [Abstract][Full Text] [Related]
3. Multi-scale analysis of bone chemistry, morphology and mechanics in the oim model of osteogenesis imperfecta.
Bart ZR; Hammond MA; Wallace JM
Connect Tissue Res; 2014 Aug; 55 Suppl 1():4-8. PubMed ID: 25158170
[TBL] [Abstract][Full Text] [Related]
4. Fourier transform infrared imaging spectroscopy (FT-IRIS) of mineralization in bisphosphonate-treated oim/oim mice.
Camacho NP; Carroll P; Raggio CL
Calcif Tissue Int; 2003 May; 72(5):604-9. PubMed ID: 12574874
[TBL] [Abstract][Full Text] [Related]
5. Age- and genotype-dependence of bone material properties in the osteogenesis imperfecta murine model (oim).
Grabner B; Landis WJ; Roschger P; Rinnerthaler S; Peterlik H; Klaushofer K; Fratzl P
Bone; 2001 Nov; 29(5):453-7. PubMed ID: 11704498
[TBL] [Abstract][Full Text] [Related]
6. Oim mice exhibit altered femur and incisor mineral composition and decreased bone mineral density.
Phillips CL; Bradley DA; Schlotzhauer CL; Bergfeld M; Libreros-Minotta C; Gawenis LR; Morris JS; Clarke LL; Hillman LS
Bone; 2000 Aug; 27(2):219-26. PubMed ID: 10913914
[TBL] [Abstract][Full Text] [Related]
7. Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.
Oestreich AK; Carleton SM; Yao X; Gentry BA; Raw CE; Brown M; Pfeiffer FM; Wang Y; Phillips CL
Osteoporos Int; 2016 Jan; 27(1):161-70. PubMed ID: 26179666
[TBL] [Abstract][Full Text] [Related]
8. Bone mineralization in an osteogenesis imperfecta mouse model studied by small-angle x-ray scattering.
Fratzl P; Paris O; Klaushofer K; Landis WJ
J Clin Invest; 1996 Jan; 97(2):396-402. PubMed ID: 8567960
[TBL] [Abstract][Full Text] [Related]
9. Quantitative polarized Raman spectroscopy in highly turbid bone tissue.
Raghavan M; Sahar ND; Wilson RH; Mycek MA; Pleshko N; Kohn DH; Morris MD
J Biomed Opt; 2010; 15(3):037001. PubMed ID: 20615030
[TBL] [Abstract][Full Text] [Related]
10. Mineral changes in a mouse model of osteogenesis imperfecta detected by Fourier transform infrared microscopy.
Camacho NP; Landis WJ; Boskey AL
Connect Tissue Res; 1996; 35(1-4):259-65. PubMed ID: 9084664
[TBL] [Abstract][Full Text] [Related]
11. Raman and Fourier Transform Infrared (FT-IR) Mineral to Matrix Ratios Correlate with Physical Chemical Properties of Model Compounds and Native Bone Tissue.
Taylor EA; Lloyd AA; Salazar-Lara C; Donnelly E
Appl Spectrosc; 2017 Oct; 71(10):2404-2410. PubMed ID: 28485618
[TBL] [Abstract][Full Text] [Related]
12. Strontium Ranelate Reduces the Fracture Incidence in a Growing Mouse Model of Osteogenesis Imperfecta.
Shi C; Hu B; Guo L; Cao P; Tian Y; Ma J; Chen Y; Wu H; Hu J; Deng L; Zhang Y; Yuan W
J Bone Miner Res; 2016 May; 31(5):1003-14. PubMed ID: 26679066
[TBL] [Abstract][Full Text] [Related]
13. Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone.
Miller E; Delos D; Baldini T; Wright TM; Pleshko Camacho N
Calcif Tissue Int; 2007 Sep; 81(3):206-14. PubMed ID: 17660935
[TBL] [Abstract][Full Text] [Related]
14. Alendronate treatment for infants with osteogenesis imperfecta: demonstration of efficacy in a mouse model.
McCarthy EA; Raggio CL; Hossack MD; Miller EA; Jain S; Boskey AL; Camacho NP
Pediatr Res; 2002 Nov; 52(5):660-70. PubMed ID: 12409511
[TBL] [Abstract][Full Text] [Related]
15. Overconstrained library-based fitting method reveals age- and disease-related differences in transcutaneous Raman spectra of murine bones.
Maher JR; Inzana JA; Awad HA; Berger AJ
J Biomed Opt; 2013 Jul; 18(7):077001. PubMed ID: 23817761
[TBL] [Abstract][Full Text] [Related]
16. The material basis for reduced mechanical properties in oim mice bones.
Camacho NP; Hou L; Toledano TR; Ilg WA; Brayton CF; Raggio CL; Root L; Boskey AL
J Bone Miner Res; 1999 Feb; 14(2):264-72. PubMed ID: 9933481
[TBL] [Abstract][Full Text] [Related]
17. Altered lacunar and vascular porosity in osteogenesis imperfecta mouse bone as revealed by synchrotron tomography contributes to bone fragility.
Carriero A; Doube M; Vogt M; Busse B; Zustin J; Levchuk A; Schneider P; Müller R; Shefelbine SJ
Bone; 2014 Apr; 61():116-24. PubMed ID: 24373921
[TBL] [Abstract][Full Text] [Related]
18. The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta.
Delos D; Yang X; Ricciardi BF; Myers ER; Bostrom MP; Camacho NP
J Orthop Res; 2008 Feb; 26(2):153-64. PubMed ID: 17729310
[TBL] [Abstract][Full Text] [Related]
19. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse.
Kalajzic I; Terzic J; Rumboldt Z; Mack K; Naprta A; Ledgard F; Gronowicz G; Clark SH; Rowe DW
Endocrinology; 2002 May; 143(5):1594-601. PubMed ID: 11956140
[TBL] [Abstract][Full Text] [Related]
20. Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress.
Misof K; Landis WJ; Klaushofer K; Fratzl P
J Clin Invest; 1997 Jul; 100(1):40-5. PubMed ID: 9202055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]